ArteroProtect Vitamin K2 and Policosanol Supplement May Help Lower Bad Cholesterol

Photo © iStockphoto.com/janulla

In a prospective clinical study recently published by the International Journal of Pharmaceutical Science Invention,¹ researchers examined the efficacy of Abela Pharm’s (Belgrade, Serbia) proprietary ArteroProtect dietary supplement in improving measures of heart health. The ArteroProtect compound is based on octacosanol (the main constituent of policosanol) and vitaMK7, Gnosis S.p.A.’s (Desio, Italy) patented natural vitamin K2 ingredient. The study found that ArteroProtect, used alone, could contribute to lowering levels of bad cholesterol and triglycerides. In combination with a statin, it can achieve target values of HDL cholesterol.

The study was facilitated by 76 doctors in primary health centers throughout the Republic of Serbia, where elevated blood fats have been observed in the general population. HDL cholesterol and LDL cholesterol was measured for all participants over the course of two visits to health centers. In total, 6,595 subjects participated in the study, with 4,031 subjects taking the ArteroProtect supplement and 2,564 subjects who were not taking it. Most participants in the study group were between 61 and 70 years of age, while in the control group most subjects were between 41 and 60 years of age. Most of the subjects in both the study and control groups were diagnosed with hypertension, with 64.3% of subjects in the study group receiving statins or other medications (35.7% did not) during the time of the study. In the control group, 57.2% of subjects were on statins or other drugs, while 42.8% were not. In addition, many subjects in both groups were cigarette smokers and were considered obese. Taken together, these etiological factors indicate higher risk for cardiovascular diseases, researchers said.

During the course of the study, doctors measured the levels of cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol of both groups. In the ArteroProtect group, mean values of cholesterol, triglycerides, and LDL cholesterol decreased, and of HDL cholesterol increased. Moreover, subjects taking ArteroProtect and a statin saw significantly decreased LDL cholesterol levels and significantly increased HDL cholesterol levels. Based on the results, the study authors concluded that the ArteroProtect dietary supplement used alone can contribute to lowering levels of blood fat, and in combination with a statin it can achieve the target value of HDL cholesterol.

References:

1. Jovanovic J et al. “Efficiency of use of dietary supplement ArteroProtect in prevention of cardiovascular diseases.” International Journal of Pharmaceutical Science Invention, vol. 6 no. 2 (February 2017): 17-20